Zobrazeno 1 - 10
of 484
pro vyhledávání: ''
Autor:
Carmen Spaccarotella, Nicola Corcione, Salvatore De Rosa, Serena Migliarino, Giovanni Matera, Angela Quirino, Cinzia Peronace, Aida Giancotti, Giorgio Settimo Barreca, Annalisa Mongiardo, Antonio Curcio, Nadia Marascio, Ciro Indolfi
Publikováno v:
Journal of Cardiovascular Medicine. 21:975-979
Aims Patients with acute coronary syndrome (ACS) often arrive in the catheterization (cath) lab directly from the field or an emergency department without an accurate triage for Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.A
Publikováno v:
Journal of Cardiovascular Pharmacology
Supplemental Digital Content is Available in the Text.
Background: Preventing myocardial ischemia–reperfusion injury in on-pump cardiac surgeries remains an enormous challenge. Sevoflurane postconditioning has been effective at overcoming this
Background: Preventing myocardial ischemia–reperfusion injury in on-pump cardiac surgeries remains an enormous challenge. Sevoflurane postconditioning has been effective at overcoming this
Publikováno v:
Journal of Cardiovascular Nursing. 34:244-249
Background Catheter-directed thrombolysis (CDT) is one of the emerging venous thromboembolism management modalities. There are fairly limited data regarding the use of direct-thrombin inhibitors (DTIs) in patients with heparin-induced thrombocytopeni
Autor:
Nancy J. Rothwell, Calvin Heal, Craig J. Smith, Stephen J. Hopkins, Karen Hopkins, Andy Vail, Pippa J. Tyrrell, Adrian R Parry-Jones, Stuart M. Allan, Sylvia Scarth, Sharon Hulme, Margaret E. Hoadley
Publikováno v:
Smith, C J, Hulme, S, Vail, A, Heal, C, Parry-Jones, A R, Scarth, S, Hopkins, K, Hoadley, M, Allan, S M, Rothwell, N J, Hopkins, S J & Tyrrell, P J 2018, ' SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke) : A Randomized Controlled Phase 2 Trial ', Stroke, vol. 49, no. 5, pp. 1210-1216 . https://doi.org/10.1161/STROKEAHA.118.020750
Background and Purpose— The proinflammatory cytokine IL-1 (interleukin-1) has a deleterious role in cerebral ischemia, which is attenuated by IL-1 receptor antagonist (IL-1Ra). IL-1 induces peripheral inflammatory mediators, such as interleukin-6,
Autor:
Carlos Eduardo Poli-de-Figueiredo, Marcos Roberto de Sousa, Sandra C. Fuchs, Evandro José Cesarino, Otavio Berwanger, Hilton Chaves, Rosane Paixão Schlatter, Antonio Claudio Lucas da Nóbrega, Luiz César Nazário Scala, José F. Vilela-Martin, José Albuquerque de Figueiredo Neto, Marco Antonio Mota Gomes, Caroline Nespolo de David, Leila Beltrami Moreira, Guilhermo Prates Sesin, João Guilherme Alves, Fernando Nobre, Luiz Aparecido Bortolotto, Flávio Danni Fuchs, Iran Castro, Abrahão Afiune Neto, Paul K. Whelton, Andréa Araujo Brandão, André Avelino Steffens, Ricardo Pereira Silva, Letícia Rafaelli, Dário Celestino Sobral Filho, Miguel Gus, Ana Luiza Lima Sousa, Roberto Jorge da Silva Franco
Publikováno v:
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Made available in DSpace on 2022-04-28T19:09:40Z (GMT). No. of bitstreams: 0 Previous issue date: 2018-04-01 Ministry of Science and Technology Background: To determine the effectiveness of low-dose diuretic therapy to achieve an optimal level of blo
Autor:
Didier Smadja, Cosmin Alecu, Tony Altarcha, Manvel Aghasaryan, Djibril Soumah, Nicolas Chausson
Publikováno v:
Stroke. 49:2526-2528
Background and Purpose— Acute ischemic strokes under vitamin K antagonist (VKA) treatment are not uncommon, but intravenous thrombolysis (IVT) is not recommended for international normalized ratio (INR) >1.7 because of the excess bleeding risk. How
Publikováno v:
Journal of Cardiovascular Pharmacology
Atrial fibrillation (AF) is a common clinically significant cardiac arrhythmia. This phase 3 randomized, double-blind, placebo-controlled trial assessed the efficacy and safety of vernakalant hydrochloride for the pharmacological conversion of AF to
Autor:
Kazuyoshi Hina, Shigeshi Kamikawa, Issei Komatsubara, Shozo Kusachi, Hiroshi Kawamura, Takashi Murakami, Hirosuke Yamaji, Shunichi Higashiya, Masaaki Murakami
Publikováno v:
Journal of Cardiovascular Pharmacology
Background Some patients with atrial fibrillation (AF) received underdoses of non-vitamin K antagonist oral anticoagulants (NOACs) in the real world. Underdosing is defined as administration of a dose lower than the manufacturer recommended dose. Obj
Publikováno v:
Coronary Artery Disease. 28:11-16
Objective The aim of this study was to compare the role of intracoronary (IC) verapamil versus sodium nitroprusside (SNP) in the prevention of microvascular obstruction (MVO) during a primary percutaneous coronary intervention (pPCI). Background A he
Autor:
Travis P. Gratton, Jeffrey A. Brinker, Matthew J. Czarny, Roger S. Blumenthal, Julie M. Miller, Khalil Ibrahim, Jon R. Resar, William Clarke, William R. Herzog, Thomas S. Kickler, Peter V. Johnston, Steven P. Schulman, Matthews Chacko, Chao Wei Hwang, Ali R. Keramati, Rakesh R. Goli, Jeffrey C. Trost, Rani K. Hasan, John W. McEvoy, David R. Thiemann
Publikováno v:
Circulation. 137:307-309
Fentanyl is a potent opiate commonly administered during cardiac catheterization procedures in North America.1 The question of whether fentanyl could have adverse consequences in patients undergoing percutaneous coronary intervention (PCI) is raised